BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19937438)

  • 1. Neurofibromatosis type 1 and high-grade tumors of the central nervous system.
    Rosenfeld A; Listernick R; Charrow J; Goldman S
    Childs Nerv Syst; 2010 May; 26(5):663-7. PubMed ID: 19937438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients.
    Guillamo JS; Créange A; Kalifa C; Grill J; Rodriguez D; Doz F; Barbarot S; Zerah M; Sanson M; Bastuji-Garin S; Wolkenstein P;
    Brain; 2003 Jan; 126(Pt 1):152-60. PubMed ID: 12477702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis type 1 and sporadic optic gliomas.
    Singhal S; Birch JM; Kerr B; Lashford L; Evans DG
    Arch Dis Child; 2002 Jul; 87(1):65-70. PubMed ID: 12089128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the central nervous system manifestations of neurofibromatosis type 1.
    Nix JS; Blakeley J; Rodriguez FJ
    Acta Neuropathol; 2020 Apr; 139(4):625-641. PubMed ID: 30963251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1.
    Romo CG; Piotrowski AF; Campian JL; Diarte J; Rodriguez FJ; Bale TA; Dahiya S; Gutmann DH; Lucas CG; Prichett L; Mellinghoff I; Blakeley JO
    Neuro Oncol; 2023 Aug; 25(8):1474-1486. PubMed ID: 36840626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
    Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
    J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis type 1 and malignancy in childhood.
    Varan A; Şen H; Aydın B; Yalçın B; Kutluk T; Akyüz C
    Clin Genet; 2016 Mar; 89(3):341-5. PubMed ID: 26073032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologically benign, clinically aggressive: Progressive non-optic pathway pilocytic astrocytomas in adults with NF1.
    Strowd RE; Rodriguez FJ; McLendon RE; Vredenburgh JJ; Chance AB; Jallo G; Olivi A; Ahn ES; Blakeley JO
    Am J Med Genet A; 2016 Jun; 170(6):1455-61. PubMed ID: 26992069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group.
    Ater JL; Xia C; Mazewski CM; Booth TN; Freyer DR; Packer RJ; Sposto R; Vezina G; Pollack IF
    Cancer; 2016 Jun; 122(12):1928-36. PubMed ID: 27061921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonoptic pathway tumors in children with neurofibromatosis type 1.
    Mahdi J; Goyal MS; Griffith J; Morris SM; Gutmann DH
    Neurology; 2020 Aug; 95(8):e1052-e1059. PubMed ID: 32300062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gliomas in patients with neurofibromatosis type 1.
    Albers AC; Gutmann DH
    Expert Rev Neurother; 2009 Apr; 9(4):535-9. PubMed ID: 19344304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
    Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
    J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soft tissue sarcomas and central nervous system tumors in children with neurofibromatosis type 1.
    Cecen E; Ince D; Uysal KM; Ozer E; Cetingoz R; Ozguven AA; Cakmakci H; Sarialioglu F; Olgun N
    Childs Nerv Syst; 2011 Nov; 27(11):1885-93. PubMed ID: 21442270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic study of glioblastoma in children with neurofibromatosis type 1.
    Huttner AJ; Kieran MW; Yao X; Cruz L; Ladner J; Quayle K; Goumnerova LC; Irons MB; Ullrich NJ
    Pediatr Blood Cancer; 2010 Jul; 54(7):890-6. PubMed ID: 20310005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas.
    Li J; Perry A; James CD; Gutmann DH
    Neurology; 2001 Apr; 56(7):885-90. PubMed ID: 11294925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do children with optic pathway tumors have an increased frequency of other central nervous system tumors?
    Korones DN; Padowski J; Factor BA; Constine LS
    Neuro Oncol; 2003 Apr; 5(2):116-20. PubMed ID: 12672283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis type 1, gastrointestinal stromal tumor, leiomyosarcoma and osteosarcoma: four cases of rare tumors and a review of the literature.
    Afşar CU; Kara IO; Kozat BK; Demiryürek H; Duman BB; Doran F
    Crit Rev Oncol Hematol; 2013 May; 86(2):191-9. PubMed ID: 23218951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Brain stem tumors associated with neurofibromatosis type 1. Presentation of 20 infantile patients].
    Pascual Castroviejo I; Pascual Pascual S; Velázquez Fragua R; Viaño J; Garcia Segura JM
    Neurologia; 2007 Dec; 22(10):846-52. PubMed ID: 17671854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of brainstem gliomas in patients with neurofibromatosis 1.
    Pollack IF; Shultz B; Mulvihill JJ
    Neurology; 1996 Jun; 46(6):1652-60. PubMed ID: 8649565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
    Fangusaro J; Onar-Thomas A; Young Poussaint T; Wu S; Ligon AH; Lindeman N; Banerjee A; Packer RJ; Kilburn LB; Goldman S; Pollack IF; Qaddoumi I; Jakacki RI; Fisher PG; Dhall G; Baxter P; Kreissman SG; Stewart CF; Jones DTW; Pfister SM; Vezina G; Stern JS; Panigrahy A; Patay Z; Tamrazi B; Jones JY; Haque SS; Enterline DS; Cha S; Fisher MJ; Doyle LA; Smith M; Dunkel IJ; Fouladi M
    Lancet Oncol; 2019 Jul; 20(7):1011-1022. PubMed ID: 31151904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.